✨
AI Summary
- Dr. Marty Makary, new FDA head, exposes systemic issues: unnecessary surgeries, inflated medical pricing, and failures in medical education
- Hospital bills often have little correlation to actual care provided; understanding medical pricing empowers patients to negotiate and advocate
- The FDA under Makary will take a new direction shaped by his specific views on healthcare reform and industry accountability